Define your brief
Ingredient direction, format, intended users, target market and packaging.
MARKET REFERENCE / NOW Foods
C-1000 with Rose Hips Tablets
A historical vitamin C and rose-hips tablet label, distinct from the bioflavonoid capsule reference.
TabletsNOW Foods
The pictured C-1000 with rose hips product is presented as a historical label reference. The NIH record is marked off market; it does not establish current retail availability or sustained-release performance. For a separate project, discuss vitamin C and rose-hips targets, tablet preferences and packaging.
Discuss a similar product direction ↗Send a project inquiry →Original image and brand are shown for market reference. This is not a Dio Bio finished product or an offer to resell the pictured brand.
PRODUCT KEYWORDS
Build your brief.
C-1000 with Rose Hips Tablets · Tablets · Private label development · Custom packaging
- Reference brand
- NOW Foods
- Product direction
- C-1000 with Rose Hips Tablets
- Dosage form
- Tablets
- Development status
- Formulation, ingredient suitability and manufacturing feasibility to be reviewed
- Packaging
- Your own branding and packaging to be developed
- Catalog keywords
- Vitamin C, C-1000, rose hips, tablets, historical label
Explore the collection
Compare formats and ingredient directions for your next product brief.
All products →YOUR NEXT STEP
Turn this direction into a project.
Review the specification
Sample scope, agreed formulation, serving details and label artwork for your project.
Before you inquire.
What details should I confirm?
For OEM / ODM, agree ingredient identities, serving specification, sample scope and packaging for your own project.
Which documents can I request?
Send the product reference and requested document list. Product and batch document availability is checked for your destination.
How should I use this product image?
The image illustrates a product or packaging direction. Third-party brands are development references; the final formulation and label for your brand are agreed separately.